The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

CVS Health has secured a major healthcare deal, winning a multi-year pharmacy benefits contract with CalPERS, outbidding rival UnitedHealth. The deal marks a significant win for CVS's Caremark unit ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...

CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost less," CVS Caremark told customers in May.